Dr. Leonid Shunyakov, MD

Dr. Shunyakov practices at Citizens Memorial Hospital in Bolivar, Missouri, part of Citizens Memorial Healthcare.

Dr. Shunyakov's NPI, 1396709895, was assigned on April 13, 2006. Dr. Shunyakov holds Missouri license 2005002905.

Dr. Shunyakov's primary practice is Citizens Memorial Hospital, at 1500 N Oakland, Bolivar, MO 65613 in Polk County. The practice phone is (417) 326-6000.

Dr. Shunyakov's primary practice is Citizens Memorial Hospital in Bolivar, Missouri, part of Citizens Memorial Healthcare. Dr. Shunyakov is also affiliated with Mercy Hospital Springfield. The medical group on file is Citizens Memorial. Dmand AI also links Dr. Shunyakov to 2 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shunyakov practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Shunyakov's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Shunyakov's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 157,461 Medicare services from Dr. Shunyakov across 40 procedure codes in 2024, for 379 Medicare patients. Medicare paid $3,096,083 for them. Every service was in an office.

CMS counts 379 Medicare patients who saw Dr. Shunyakov in 2024. The largest group is 65 to 74, with 152 patients. 72% of them have high blood pressure, and 58% have cancer. 13% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shunyakov's median patient age at 71, with 53% women.

In 2024, Dr. Shunyakov wrote 5,150 Medicare Part D claims for 490 patients. 71% of them were for generic drugs. CMS names the drug for 4,457 of them, across 100 drugs with 11 or more claims each, at $9,585,316 in total drug cost. In 2023, CMS named 4,243 claims across 101 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Shunyakov for performance year 2024, reported individually. Dr. Shunyakov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shunyakov as offering telehealth.

Dmand AI links 3 papers to Dr. Shunyakov, published from 2014 to 2024. 2024 was the busiest year, with 2. Dr. Shunyakov has published most often in BMJ Case Rep. Dr. Shunyakov's most frequent co-author is Karel Adriaan Dicke, MD, PhD.

Dmand AI links Dr. Shunyakov to 8 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Leukemia, Lymphocytic, Chronic, B-Cell and Multiple Myeloma. Open Payments lists research payments to Dr. Shunyakov that name 2 trials.

CMS Open Payments shows 3,576 general payments to Dr. Shunyakov from 101 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Bristol-Myers Squibb Company paid the most, $753,456. It also lists 3 research payments totaling $3,511 from 2019 to 2023, naming 2 clinical trials.